Kristen Lantz

1.1k total citations
14 papers, 657 citations indexed

About

Kristen Lantz is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Kristen Lantz has authored 14 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Hematology. Recurrent topics in Kristen Lantz's work include Multiple Myeloma Research and Treatments (6 papers), Pancreatic function and diabetes (5 papers) and Peptidase Inhibition and Analysis (4 papers). Kristen Lantz is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Pancreatic function and diabetes (5 papers) and Peptidase Inhibition and Analysis (4 papers). Kristen Lantz collaborates with scholars based in United States, France and Spain. Kristen Lantz's co-authors include Klaus H. Kaestner, Franz M. Matschinsky, Marko Z. Vatamaniuk, John Brestelli, Sonia Lobo Planey, Michael McLane, Susan Hart, Henry R. Wolfe, Mitchell F. Roitman and Joshua R. Friedman and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Kristen Lantz

14 papers receiving 642 citations

Peers

Kristen Lantz
Diane H. Song United States
Theo JC Van Berkel Netherlands
Vishal A. Salunkhe Sweden
M.C.M. van Dijk Netherlands
Long Cui China
Xu Hannah Zhang United States
Marc W. Pladet United States
Tatjana Albrektsen Denmark
Wei Ren China
Yolanda F. Darlington United States
Diane H. Song United States
Kristen Lantz
Citations per year, relative to Kristen Lantz Kristen Lantz (= 1×) peers Diane H. Song

Countries citing papers authored by Kristen Lantz

Since Specialization
Citations

This map shows the geographic impact of Kristen Lantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristen Lantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristen Lantz more than expected).

Fields of papers citing papers by Kristen Lantz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristen Lantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristen Lantz. The network helps show where Kristen Lantz may publish in the future.

Co-authorship network of co-authors of Kristen Lantz

This figure shows the co-authorship network connecting the top 25 collaborators of Kristen Lantz. A scholar is included among the top collaborators of Kristen Lantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristen Lantz. Kristen Lantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Usmani, Saad Z., María‐Victoria Mateos, Vânia Hungria, et al.. (2020). Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results. Journal of Cancer Research and Clinical Oncology. 147(2). 619–631. 20 indexed citations
3.
Lantz, Kristen, et al.. (2020). Hands On Laboratory Projects For Non Science Majors: Learning Principles Of Physics In The Context Of Everyday Technology.. Papers on Engineering Education Repository (American Society for Engineering Education). 5.325.1–5.325.9. 6 indexed citations
4.
Usmani, Saad Z., María‐Victoria Mateos, Vânia Hungria, et al.. (2019). Greater Treatment Satisfaction in Patients Receiving Subcutaneous (SC) Versus Intravenous (IV) Daratumumab (DARA) for Relapsed or Refractory Multiple Myeloma (RRMM): COLUMBA. Clinical Lymphoma Myeloma & Leukemia. 19(10). e247–e248. 2 indexed citations
5.
Yan, Xiaoyu, Pamela L. Clemens, Thomas A. Puchalski, et al.. (2017). Influence of Disease and Patient Characteristics on Daratumumab Exposure and Clinical Outcomes in Relapsed or Refractory Multiple Myeloma. Clinical Pharmacokinetics. 57(4). 529–538. 26 indexed citations
6.
Clemens, Pamela L., Xiaoyu Yan, Henk M. Lokhorst, et al.. (2016). Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor and Immunomodulatory Drug Treatment. Clinical Pharmacokinetics. 56(8). 915–924. 63 indexed citations
7.
8.
Lantz, Kristen, Susan Hart, Sonia Lobo Planey, et al.. (2010). Inhibition of PTP1B by Trodusquemine (MSI‐1436) Causes Fat‐specific Weight Loss in Diet‐induced Obese Mice. Obesity. 18(8). 1516–1523. 195 indexed citations
9.
10.
Vatamaniuk, Marko Z., Rana K. Gupta, Kristen Lantz, et al.. (2006). Foxa1-Deficient Mice Exhibit Impaired Insulin Secretion due to Uncoupled Oxidative Phosphorylation. Diabetes. 55(10). 2730–2736. 53 indexed citations
11.
Lantz, Kristen & Klaus H. Kaestner. (2005). Winged-helix transcription factors and pancreatic development. Clinical Science. 108(3). 195–204. 53 indexed citations
12.
Lantz, Kristen, Marko Z. Vatamaniuk, John Brestelli, et al.. (2004). Foxa2 regulates multiple pathways of insulin secretion. Journal of Clinical Investigation. 114(4). 512–520. 145 indexed citations
13.
Lantz, Kristen, Marko Z. Vatamaniuk, John Brestelli, et al.. (2004). Foxa2 regulates multiple pathways of insulin secretion. Journal of Clinical Investigation. 114(4). 512–520. 15 indexed citations
14.
Kaestner, Klaus H., Catherine S. Lee, L. Marie Scearce, et al.. (2003). Transcriptional Program of the Endocrine Pancreas in Mice and Humans. Diabetes. 52(7). 1604–1610. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diane H. Song Breakdown of academic impact, for papers by Theo JC Van Berkel Breakdown of academic impact, for papers by Vishal A. Salunkhe Breakdown of academic impact, for papers by M.C.M. van Dijk Breakdown of academic impact, for papers by Long Cui Breakdown of academic impact, for papers by Xu Hannah Zhang Breakdown of academic impact, for papers by Marc W. Pladet Breakdown of academic impact, for papers by Tatjana Albrektsen Breakdown of academic impact, for papers by Wei Ren Breakdown of academic impact, for papers by Yolanda F. Darlington
Rankless by CCL
2026